1-4 of 4
Ute Berger, MD
Close
Sort by
Journal Articles

Concept, Feasibility and Results of the Randomized Comparison of Imatinib Combination Therapies for Chronic Myeloid Leukemia: The German CML-Study IV.

Ute Berger, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Claudia Schoch, MD, Andreas Reiter, MD, Gerhard Ehninger, MD, Thomas Fischer, MD, Alois Gratwohl, MD, Joerg Hasford, MD, Hermann Heimpel, MD, Dieter K. Hossfeld, MD, Hans-J. Kolb, MD, Stefan Krause, MD, Christoph Nerl, MD, Hans Pralle, MD, Andreas Tobler, MD, Ruediger Hehlmann, MD, The German CML-Study Group
Journal: Blood
Blood (2005) 106 (11): 1083.
https://doi.org/10.1182/blood.V106.11.1083.1083
Published: 2005
Journal Articles

Early Detection of Imminent Hematologic Relapse Due to BCR-ABL Kinase Domain Mutations in CML Patients on Imatinib Therapy by D-HPLC.

Thomas Ernst, MD, Philipp Erben, MD, Thomas Schenk, MD, Martin C. Mueller, MD, Michael Emig, MD, Sebastian Kreil, MD, Paul La Rosée, MD, Ute Berger, MD, Ruediger Hehlmann, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2005) 106 (11): 1088.
https://doi.org/10.1182/blood.V106.11.1088.1088
Published: 2005
Journal Articles

Feasibility of Imatinib Combination Therapies in a Randomized Trial for Chronic Myeloid Leukemia: The German CML-Study IV - Pilot Phase.

Ute Berger, MD, Andreas Hochhaus, MD, Andreas Reiter, MD, Markus Pfirrmann, Claudia Schoch, MD, Gerhard Ehninger, MD, Thomas Fischer, MD, Alois Gratwohl, MD, Joerg Hasford, MD, Hermann Heimpel, MD, Dieter K. Hossfeld, MD, Hans-J. Kolb, MD, Stefan Krause, MD, Christoph Nerl, MD, Hans Pralle, MD, Andreas Tobler, MD, Rüdiger Hehlmann, MD, the German CML-Study Group
Journal: Blood
Blood (2004) 104 (11): 24.
https://doi.org/10.1182/blood.V104.11.24.24
Published: 2004
Journal Articles

PEG-Interferon for Chronic Phase CML - Still an Option in the Era of Imatinib?.

Christof Scheid, MD, Andreas Draube, MD, Udo Holtick, MD, Oliver Cornely, MD, Ulrich Hacker, MD, Michael Fuchs, MD, Ute Berger, MD, Andreas Hochhaus, MD, PhD, Rüdiger Hehlmann, MD, PhD, Michael Hallek, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4662.
https://doi.org/10.1182/blood.V104.11.4662.4662
Published: 2004